Literature DB >> 23666040

High-fat and ketogenic diets in amyotrophic lateral sclerosis.

Sabrina Paganoni1, Anne-Marie Wills.   

Abstract

Amyotrophic lateral sclerosis is a fatal neurodegenerative disease. Epidemiologic data suggest that malnutrition is a common feature in amyotrophic lateral sclerosis and being overweight or obese confers a survival advantage in this patient population. In amyotrophic lateral sclerosis mouse models, a high-fat diet has been shown to lead to weight gain and prolonged survival. However, little research has been conducted to test whether nutritional interventions might ameliorate the disease course in humans. Here we review the currently available evidence supporting the potential role of dietary interventions as a therapeutic tool for amyotrophic lateral sclerosis. Ultimately, determining whether a high-fat or ketogenic diet could be beneficial in amyotrophic lateral sclerosis will require large randomized, placebo-controlled clinical trials.

Entities:  

Keywords:  ALS; amyotrophic lateral sclerosis; diet; fat; ketogenic

Mesh:

Year:  2013        PMID: 23666040      PMCID: PMC4438106          DOI: 10.1177/0883073813488669

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  37 in total

Review 1.  Nutritional assessment and survival in ALS patients.

Authors:  J C Desport; P M Preux; C T Truong; L Courat; J M Vallat; P Couratier
Journal:  Amyotroph Lateral Scler Other Motor Neuron Disord       Date:  2000-03

Review 2.  Nutritional management in MND/ALS patients: an evidence based review.

Authors:  Catherine Heffernan; Crispin Jenkinson; Tricia Holmes; Gene Feder; Richard Kupfer; P Nigel Leigh; Sue McGowan; Alan Rio; Paul Sidhu
Journal:  Amyotroph Lateral Scler Other Motor Neuron Disord       Date:  2004-06

3.  Population-based case-control study of amyotrophic lateral sclerosis in western Washington State. II. Diet.

Authors:  L M Nelson; C Matkin; W T Longstreth; V McGuire
Journal:  Am J Epidemiol       Date:  2000-01-15       Impact factor: 4.897

4.  Factors correlated with hypermetabolism in patients with amyotrophic lateral sclerosis.

Authors:  J C Desport; P M Preux; L Magy; Y Boirie; J M Vallat; B Beaufrère; P Couratier
Journal:  Am J Clin Nutr       Date:  2001-09       Impact factor: 7.045

Review 5.  The synthesis and transport of lipids for axonal growth and nerve regeneration.

Authors:  J E Vance; R B Campenot; D E Vance
Journal:  Biochim Biophys Acta       Date:  2000-06-26

6.  Uptake of lipoproteins for axonal growth of sympathetic neurons.

Authors:  E I Posse De Chaves; D E Vance; R B Campenot; R S Kiss; J E Vance
Journal:  J Biol Chem       Date:  2000-06-30       Impact factor: 5.157

7.  Amyotrophic lateral sclerosis in Olmsted County, Minnesota, 1925 to 1998.

Authors:  Eric J Sorenson; Andrew P Stalker; Leonard T Kurland; Anthony J Windebank
Journal:  Neurology       Date:  2002-07-23       Impact factor: 9.910

Review 8.  Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND).

Authors:  R G Miller; J D Mitchell; M Lyon; D H Moore
Journal:  Cochrane Database Syst Rev       Date:  2002

9.  Premorbid body mass index and risk of amyotrophic lateral sclerosis.

Authors:  Éilis J O'Reilly; Hao Wang; Marc G Weisskopf; Kathryn C Fitzgerald; Guido Falcone; Marjorie L McCullough; Michael Thun; Yikyung Park; Laurence N Kolonel; Alberto Ascherio
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2012-10-29       Impact factor: 4.092

10.  Caprylic triglyceride as a novel therapeutic approach to effectively improve the performance and attenuate the symptoms due to the motor neuron loss in ALS disease.

Authors:  Wei Zhao; Merina Varghese; Prashant Vempati; Anastasiya Dzhun; Alice Cheng; Jun Wang; Dale Lange; Amanda Bilski; Irene Faravelli; Giulio Maria Pasinetti
Journal:  PLoS One       Date:  2012-11-07       Impact factor: 3.240

View more
  3 in total

1.  Pre-morbid type 2 diabetes mellitus is not a prognostic factor in amyotrophic lateral sclerosis.

Authors:  Sabrina Paganoni; Theodore Hyman; Amy Shui; Peggy Allred; Matthew Harms; Jingxia Liu; Nicholas Maragakis; David Schoenfeld; Hong Yu; Nazem Atassi; Merit Cudkowicz; Timothy M Miller
Journal:  Muscle Nerve       Date:  2015-06-01       Impact factor: 3.217

2.  International Recommendations for the Management of Adults Treated With Ketogenic Diet Therapies.

Authors:  Mackenzie C Cervenka; Susan Wood; Manny Bagary; Antoaneta Balabanov; Eduard Bercovici; Mesha-Gay Brown; Orrin Devinsky; Cherubino Di Lorenzo; Colin P Doherty; Elizabeth Felton; Laura A Healy; Pavel Klein; Magnhild Kverneland; Danielle Lambrechts; Jennifer Langer; Janak Nathan; Jude Munn; Patty Nguyen; Matthew Phillips; Kelly Roehl; Adrianna Tanner; Clare Williams; Beth Zupec-Kania
Journal:  Neurol Clin Pract       Date:  2021-10

3.  Pridopidine modifies disease phenotype in a SOD1 mouse model of amyotrophic lateral sclerosis.

Authors:  Héctor M Estévez-Silva; Tomás Mediavilla; Bruno Lima Giacobbo; Xijia Liu; Fahad R Sultan; Daniel J Marcellino
Journal:  Eur J Neurosci       Date:  2022-02-12       Impact factor: 3.698

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.